Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 5, 2004, Pages 330-334

  Sopena, Nieves ^a   Pedro Botet, Maria Luisa ^a   Sabrià, Miquel ^a   García Parés, Delia ^a   Reynaga, Esteban ^a   García Nuñez, Marian ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; CREATINE KINASE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; CREATINE KINASE BLOOD LEVEL; DIARRHEA; EPIDEMIOLOGICAL DATA; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPONATREMIA; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NONHUMAN; PROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHLAMYDIA INFECTIONS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INCIDENCE; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPAIN; SURVIVAL RATE;

EID: 3242750567     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020091     Document Type: Article

References (28)

1. Bochud PY, Moser F, Erard P, Verdon F, Studer JP, Villard G, et al. Community-acquired pneumonia. A prospective outpatient study. Medicine 2001; 80: 75-87.
2. Marston BJ, Plouffe JF, File TM, Hackman BAA, Salstrom SSJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization; results of a population based active surveillance study in Ohio. Arch Intern Med 1997; 157: 1709-18.
3. Vergis EN, Yu VL. New directions for future studies of community-acquired pneumonia: optimizing impact on patient care. Eur J Clin Microbiol Infect Dis 1999; 18: 847-51.
4. Sopena N, Sabrià M, Pedro-Botet ML, Manterola J, Matas L, Domínguez J, et al. Prospective study of community-acquired pneumonia of bacterial aetiology in adults. Eur J Clin Microbiol Infect Dis 1999; 18: 852-8.
5. Rosón B, Carratalà J, Dorca J, Casanova A, Manresa F, Gudiol F. Aetiology, reasons for hospitalization, risk classes, and outcome of community-acquired pneumonia in patients hospitalized on the basis on conventional admission criteria. Clin Infect Dis 2001; 33: 158-65.
6. Gutierrez F, Masiá M, Rodriguez JC, Ayelo A, Soldán B, Cebrián L, et al. Evaluation of immunochromatographic Binax Now assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003; 36: 286-92.
7. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101: 508-15.
8. Lieberman D, Schlaeffer F, Boldur I, Lieberman D, Horowitz S, Friedman MG, et al. Multiple pathogen in adult patients admitted with community-acquired pneumonia: a 1-y prospective study of 346 consecutive patients. Thorax 1996; 51: 179-84.
9. Gupta SK, Sarosi GA. The role of atypical pathogens in community-acquired pneumonia. Med Clin North Am 2001; 85(6): 1349-65.
10. Alvarez J, Oyaga N, Escofet D, Codony F, Orcau A, Maria Oliva J. Community-acquired legionellosis in the Barcelona (Spain) region between 1992 and 1999: epidemiological characteristics and diagnostic methods. Med Clin (Barc) 2001; 117: 495-6.
11. Kauppinen MT, Saillu P. Pneumonia due to Chlamydia pneumoniae: prevalence features, diagnosis and treatment. Clin Infect Dis 1995; 21(Suppl 3): S244-52.
12. Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach FJ, et al. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 1996; 22: 958-64.
13. Almirall J, Morató I, Riera F, Verdaguer A, Priu R, Coll P, et al. Incidence of community-acquired pneumonias and occurrence of Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J 1993; 6: 14-8.
14. File TM, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998; 12: 569-92.
15. Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia: aetiology, prognosis and treatment. Am Rev Respir Dis 1990; 142: 369-73.
16. Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjälä H. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996; 51: 185-9.
17. Helbig JH, Uldum SA, Luck PC, Harrison TG. Detection of Legionella pneumonia antigen in urine samples by the Binax NOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urine Antigen EIA. J Med Microbiol 2001; 50(6): 509-16.
18. Miller AC. Early clinical differentiation between Legionnaires' disease and other sporadic pneumonias. Ann Inter Med 1979; 90: 526-8.
19. Helms CM, Winer JP, Sturm RH, Renner ED, Finegold SM. Comparative features of pneumococcal, Mycoplasma and Legionnaires' disease pneumonias. Ann Intern Med 1979; 90: 543-7.
20. Granados A, Podzamzer D, Gudiol F, Manresa F. Pneumonia due to Legionella pneumophila and pneumococal pneumonia: similarities and differences on presentation. Eur Resp J 1989; 2: 130-4.
21. Woodhead MA, MacFarlane JT. Comparative clinical and laboratory features of Legionella with pneumococcal and Mycoplasma pneumonias. Br J Dis Chest 1987; 81: 133-8.
22. Watanakunakorn C, Bailey TA. Adult bacteraemic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases. Arch Intern Med 1997; 157: 1965-71.
23. File TM, Plouffe JF, Breiman RF, Skelton SK. Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia. Clin Infect Dis 1999; 29: 426-8.
24. Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiarty M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1456-61.
25. Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia: a review of 56 hospitalized adult patients. Chest 1996; 109: 1243-9.
26. Mulazimoglu L, Yu VL. Chest 2001; 120(4): 1409.
27. Sopena N, Sabrià-Leal M, Pedro-Botet ML, Padilla E, Domínguez, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumomas. Chest 1998; 113: 1195-200.
28. Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, et al. Clinical presentation of Chlamydia community-acquired pneumonia in adults. Chest 2002; 121: 1776-81.